A

Alibion AG

10 employees

Alibion developed the drug potentially capable of reversing inflammation and bone erosion in a very well defined population of patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Drug development
Licensing
Preclinical development

Date founded

2018

Funding rounds raised

Total raised

$10K

from 1 investors over 1 rounds

A

Alibion AG raised $10K on July 9, 2019

Investors: Venture Kick

FAQ